Additionally, inhibition of DCLK1 kinase activity by DCLK1-IN-1 treatment significantly reduced XRCC5 phosphorylation in CRC cells, while no alteration in the level of total XRCC5 was observed (Figure 3F and Figure S5C). This evidence concerns the gene XRCC5 and colorectal carcinoma.